Aktis Oncology AKTS Earnings Call Transcripts

NASDAQ AKTS
$16.85 +0.03 (+0.18%)
At close: Oct 29, 2026 · 4:00 PM EDT
10 earnings calls on file for Aktis Oncology, from Q2 2020 to Q4 2022. Each transcript opens in a new tab.
Latest earnings call

Aktis Oncology Q4 2022 Earnings Call

Sep 12, 2022 6,703 words · 29 min read
  • Tom SepenzisDirector, Investor Relations
  • Jeff ShealyFounder and Chief Executive Officer
  • Ken BollerChief Financial Officer
  • Dave AicheleVice President, Business Development
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Aktis Oncology Earnings Call Transcripts

Calls10
LatestSep 12, 2022
SinceQ2 2020

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 10 Aktis Oncology transcripts Register to get access to Aktis Oncology’s earnings call transcripts.